Behavior of plasma glucagon in experimental fasting and somatostatin test in islet cell tumors
Drost, H.; Berger, M.; Berchtold, P.; Wiegelmann, W.; Zimmermann, H.; Gries, F.A.
Die Medizinische Welt 27(28): 1381-1383
1976
ISSN/ISBN: 0025-8512 PMID: 183080 Document Number: 108869
Document emailed within 1 workday
Related Documents
Hetenyi, G.; Kovacevic, N.; Hall, S.E.; Vranic, M. 1976: Plasma glucagon in pups, decreased by fasting, unaffected by somatostatin or hypoglycemia American Journal of Physiology 231(5 Pt. 1): 1377-1382Yano, T.; Yamamoto, N.; Fujimori, K.; Inamori, S.; Hayashi, H.; Mizumoto, R. 1982: Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack American Journal of Gastroenterology 77(6): 387-391
Llorente, I.; Goñi, M.J.; Forga, L.; Monreal, M.; Lizcano, F.; Moncada, E. 1992: Clinical usefulness of the glucagon test in the study of pancreatic islet cell function Revista de Medicina de la Universidad de Navarra 37(1): 25-29
Howard, J.M.; Gohara, A.F.; Cardwell, R.J. 1989: Malignant islet cell tumor of the pancreas associated with high plasma calcitonin and somatostatin levels Surgery 105(2 Part 1): 227-229
Myers, N.C.; Andrews, G.A.; Chard-Bergstrom, C. 1997: Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats American Journal of Veterinary Research 58(6): 615-620
Thuesen, B.; Schaffalitzky de Muckadell, O.B.; Holst, J.J.; Bahnsen, M. 1987: The relationship of secretin and somatostatin levels in plasma to glucose administration and acid secretion during fasting American Journal of Gastroenterology 82(8): 723-726
Gronda, C.; Rossi, J.P.; Gagliardino, J.J. 1987: Relationship between insulin secretion and rat islet plasma membrane Ca2+-ATPase during short-term fasting Acta Physiologica et Pharmacologica Latinoamericana: Organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia 37(2): 245-256
Ferrara, J.J.; Fucci, J.C.; Benson, J.B. 1985: Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion Connecticut Medicine 49(12): 777-780
Simard, S.J. 1974: Diagnostic importance of plasma catecholamines in the glucagon test for pheochromocytoma L'Union Medicale du Canada 103(3): 460-465
Kornstein, M.J.; deBlois, G.G.; Williams, M.E. 1992: Unusual biclonal plasma cell dyscrasia with crystallike inclusions producing colonic tumors (plasma cell polyposis) and terminating in T-cell lymphoma Archives of Pathology and Laboratory Medicine 116(2): 168-172
Gragnoli, G.; Tanganelli, I.; Signorini, A.M. 1980: Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis Bollettino della Societa Italiana di Biologia Sperimentale 56(1): 69-75
Metrakos, P.; Yuan, S.; Agapitos, D.; Rosenberg, L. 1994: Paracrine signaling (duct-->islet) in the pancreas and maintenance of islet cell mass--potential implications for islet transplantation Transplantation Proceedings 26(2): 637-638
Angius, A.; Simpore, J.; Persico, I.; Sassu, A.; Prodi, D.A.; Musumeci, S. 2007: Methylenetetrahydrofolate Reductase Gene Polymorphisms in Burkina Faso: Impact on Plasma Fasting Homocysteine and after Methionine Loading Test Clinical Laboratory 53(1-2): 29-33
Vázquez, C.; Rovira, A.; Vázquez, J.; Badía, A.; Herrera Pombo, J.L.; Valverde, I. 1983: Behavior of total plasma immunoreactive glucagon in 2 total pancreatectomy patients Revista Clinica Espanola 170(6): 251-256
Klanfar, Z.; Lovrencić, M.; Jakovac, I.; Karapandza, N.; Silobrcić, I.; Cabrijan, T. 1988: Angiography in the diagnosis of pancreatic islet cell tumors Lijecnicki Vjesnik 110(5): 162-168
Egorov, A.V.; Kuzin, N.M.; Kondrashin, S.A.; Lotov, A.N.; Kazantseva, I.A.; Kuznetsov, N.S.; Gurevich, L.E.; Lakreeva, M.G. 2000: Treatment of malignant pancreatic islet cell tumors Khirurgiia 5: 13-17
Bonifacio, E.; Lampasona, V.; Genovese, S.; Ferrari, M.; Bosi, E. 1995: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies Journal of Immunology 155(11): 5419-5426
Heller, S.J.; Ferrari, A.P.; Carr-Locke, D.L.; Lichtenstein, D.R.; Van Dam, J.; Banks, P.A. 1996: Pancreatic duct stricture caused by islet cell tumors American Journal of Gastroenterology 91(1): 147-149
Gorden, P.; Comi, R.J.; Maton, P.N.; Go, V.L. 1989: NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Annals of Internal Medicine 110(1): 35-50
Moertel, C.G.; Johnson, C.M.; McKusick, M.A.; Martin, J.K.; Nagorney, D.M.; Kvols, L.K.; Rubin, J.; Kunselman, S. 1994: The management of patients with advanced carcinoid tumors and islet cell carcinomas Annals of Internal Medicine 120(4): 302-309